Your browser doesn't support javascript.
loading
A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers.
Wei, Jing; Sun, Huiyan; Zhang, Aimei; Wu, Xuejie; Li, Yuxiang; Liu, Jiawei; Duan, Yanting; Xiao, Fengjun; Wang, Hua; Lv, Ming; Wang, Lisheng; Wu, Chutse.
Afiliação
  • Wei J; Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.
  • Sun H; Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.
  • Zhang A; Pathology Department Weifang Heart Hospital, Shandong Province, PR China.
  • Wu X; Department of Urology, General Hospital of Chinese People's Armed Police Forces, Beijing 100039, PR China.
  • Li Y; Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.
  • Liu J; College of Basic Medicine, The Fourth Military Medical University, Xi'an, Shannxi 710000, PR China.
  • Duan Y; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, PR China.
  • Xiao F; Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.
  • Wang H; Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China; Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China.
  • Lv M; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, PR China. Electronic address: lm62033@163.com.
  • Wang L; Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China; School of Nursing, Jilin University, Changchun, Jilin 130021, PR China; Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China. Electronic add
  • Wu C; Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China; Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China. Electronic address: 13910026365@163.com.
Cell Immunol ; 331: 49-58, 2018 09.
Article em En | MEDLINE | ID: mdl-29935762

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Proteínas Proto-Oncogênicas / Receptores Proteína Tirosina Quinases / Neoplasias de Mama Triplo Negativas / Receptores de Antígenos Quiméricos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Proteínas Proto-Oncogênicas / Receptores Proteína Tirosina Quinases / Neoplasias de Mama Triplo Negativas / Receptores de Antígenos Quiméricos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article